Answers are grounded in this paper and cite their sources.
To understand the real-world use of abemaciclib in Japanese patients with early breast cancer (EBC).
No takes yet. Share an insight, caveat, or question.
Shimoi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: